Incidence and clinical course of CMV- (and herpes simplex-) infections under triple drug therapy
Greger, B.; Döller, G.; Schareck, W.D.; Müller, G.H.; Mellert, J.; Hopt, U.T.; Bockhorn, H.
Transplantation Proceedings 19(5): 4057-4060
1987
ISSN/ISBN: 0041-1345 PMID: 2823429 Document Number: 303382
Document emailed within 1 workday
Related Documents
Wassilew, S.W.; Nasemann, T. 1980: Clinical aspects and importance of human herpex simplex infections. Results of herpes antigen therapy Münchener Medizinische Wochenschrift 122(1): 25-27Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Rudinger, R. 1993: Neues und Altes zu anogenitalen Herpes-simplex-Virus-Infektionen - New and old aspects of anogenital herpes simplex virus infections - New and old aspects of anogenital Herpes simplex virus infections University of Koln. Department of Dermatology. Dermatological Meeting 68(1): 20-23
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Nouri, K.; Ricotti, C.A.; Bouzari, N.; Chen, H.; Ahn, E.; Bach, A. 2006: The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide Journal of Drugs in Dermatology: Jdd 5(2): 182-185
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Yağmur, G.ül.; Ozbal, Y.; Gökahmetoğlu, S. 2010: Investigation of herpes simplex virus (HSV) by three different methods in the clinical specimens of patients with suspected HSV infections Mikrobiyoloji Bulteni 44(1): 47-56
Thune, P.O. 1984: Herpes simplex. Clinical aspects and therapy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(4): 218-220
Baker, D.A.; Gonik, B.; Milch, P.O.; Berkowitz, A.; Lipson, S.; Verma, U. 1989: Clinical evaluation of a new herpes simplex virus ELISA: a rapid diagnostic test for herpes simplex virus Obstetrics and Gynecology 73(3 Part 1): 322-325
Turkulov, V.; Madle-Samardzija, N.; Ilić, A.; Vukadinov, J.; Canak, G. 1998: Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics Medicinski Pregled 51(9-10): 436-440
Erlich, K.S.; Jacobson, M.A.; Koehler, J.E.; Follansbee, S.E.; Drennan, D.P.; Gooze, L.; Safrin, S.; Mills, J. 1989: Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial Annals of Internal Medicine 110(9): 710-713
Kasparov, A.A.; Voĭtsekhovskaia, A.A. 1982: Anti-relapse therapy of ocular herpes patients with increased sensitivity to herpes simplex virus Vestnik Oftalmologii 5: 42-43
Kruglova, A.I.; Nikolaeva, N.P.; Niukhalova, I.V.; Barinskiĭ, I.F.; Alimbarova, L.M.; Demkin, V.V. 2004: Polymorphism of herpes simplex virus type 1 and 2 DNA from laboratory strains and clinical material from patient with genital herpes Voprosy Virusologii 49(1): 23-27
Bernal, J.N.; Suárez, M.; Schultz, R.; Sepúlveda, C. 1992: The herpes simplex virus and immunoglobulins in the amniotic fluid in pregnant women with genital herpes and a follow-up over several years: 3 clinical cases Revista Chilena de Obstetricia y Ginecologia 57(3): 184-187
Baise, G. 1987: A new approach to herpes simplex infections South African Medical Journal 71(3): 191
Feder, H.M.; White, W.B. 1987: Herpes simplex virus infections New England Journal of Medicine 316(12): 754-755
Sugase, M. 2006: Genital herpes simplex virus infections Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 252-255
Lee, S.Y. 1998: Herpes simplex virus ocular infections Drugs of Today 34(3): 241-249
Curry, S.S. 1980: Cutaneous herpes simplex infections and their treatment Cutis 26(1): 41-58